The transdermal formulation of rivastigmine improves caregiver burden and treatment adherence of patients with Alzheimer's disease under daily practice conditions

The transdermal formulation of rivastigmine improves caregiver burden and treatment adherence of patients with Alzheimer's disease under daily practice conditions

Item
http://www.wikidata.org/entity/Q34542646
Persistence and adherence with dementia pharmacotherapy: relevance of patient, provider, and system factorsA novel once-daily fixed-dose combination of memantine extended release and donepezil for the treatment of moderate to severe Alzheimer's disease: two phase I studies in healthy volunteersReal-world evaluation of compliance and preference in Alzheimer's disease treatment.A prospective non-interventional study for evaluation of quality of life in patients with Alzheimer's disease treated with rivastigmine transdermal patch.Real-world evaluation of compliance and preference in Alzheimer's disease treatment: an observational study in Taiwan.Utility of Göttingen minipigs for Prediction of Human Pharmacokinetic Profiles After Dermal Drug Application.Pharmacotherapeutic strategies in the treatment of severe Alzheimer's disease.Improving medication adherence among community-dwelling seniors with cognitive impairment: a systematic review of interventions.Efficacy of rivastigmine tartrate, transdermal system, in Alzheimer's disease.Formulations: friendly, fast, forgiving and flexible.Transdermal patches: how common are application site reactions and how severe are they?The cholinergic system in the pathophysiology and treatment of Alzheimer's disease
P2860

The transdermal formulation of rivastigmine improves caregiver burden and treatment adherence of patients with Alzheimer's disease under daily practice conditions

Item
http://www.wikidata.org/entity/Q34542646
description
2014 nî lūn-bûn
@nan
2014 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մարտին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
name
The transdermal formulation of ...... nder daily practice conditions
@ast
The transdermal formulation of ...... nder daily practice conditions
@en
The transdermal formulation of ...... nder daily practice conditions
@nl
type
label
The transdermal formulation of ...... nder daily practice conditions
@ast
The transdermal formulation of ...... nder daily practice conditions
@en
The transdermal formulation of ...... nder daily practice conditions
@nl
prefLabel
The transdermal formulation of ...... nder daily practice conditions
@ast
The transdermal formulation of ...... nder daily practice conditions
@en
The transdermal formulation of ...... nder daily practice conditions
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P577
P5875
P698
P921
P932
P356
P1433
P1476
The transdermal formulation of ...... nder daily practice conditions
@en
P2093
P2860
P304
P31
P356
P433
P478
P577
P5875
P698
P921
P932